HDAC-1/2 inhibitors (Alkermes)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC-1/2 inhibitors (Alkermes)
Drug Alias NameHDAC1/2-coREST inhibitors (Alkermes)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkermes Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A